128 related articles for article (PubMed ID: 26621336)
21. MTSS1 curtails lung adenocarcinoma immune evasion by promoting AIP4-mediated PD-L1 monoubiquitination and lysosomal degradation.
Wang Y; Jia Z; Liang C; He Y; Cong M; Wu Q; Tian P; He D; Miao X; Sun B; Yin Y; Peng C; Yao F; Fu D; Liang Y; Zhang P; Xiong H; Hu G
Cell Discov; 2023 Feb; 9(1):20. PubMed ID: 36810288
[TBL] [Abstract][Full Text] [Related]
22. circFBXO7/miR-96-5p/MTSS1 axis is an important regulator in the Wnt signaling pathway in ovarian cancer.
Wu M; Qiu Q; Zhou Q; Li J; Yang J; Zheng C; Luo A; Li X; Zhang H; Cheng X; Lu W; Liu P; Lu B; Lu Y
Mol Cancer; 2022 Jun; 21(1):137. PubMed ID: 35768865
[TBL] [Abstract][Full Text] [Related]
23. MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination.
Cong M; Wang Y; Yang Y; Lian C; Zhuang X; Li X; Zhang P; Liu Y; Tang J; Yang Q; Zhang X; Xiong H; Hu R; Hu G
Nat Cancer; 2020 Feb; 1(2):222-234. PubMed ID: 35122005
[TBL] [Abstract][Full Text] [Related]
24. Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
Abdulmawjood B; Costa B; Roma-Rodrigues C; Baptista PV; Fernandes AR
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830398
[TBL] [Abstract][Full Text] [Related]
25. A Comprehensive Characterization of Monoallelic Expression During Hematopoiesis and Leukemogenesis
Fu R; Qin P; Zou X; Hu Z; Hong N; Wang Y; Jin W
Front Cell Dev Biol; 2021; 9():702897. PubMed ID: 34722498
[TBL] [Abstract][Full Text] [Related]
26. Early and late stage MPN patients show distinct gene expression profiles in CD34
Baumeister J; Maié T; Chatain N; Gan L; Weinbergerova B; de Toledo MAS; Eschweiler J; Maurer A; Mayer J; Kubesova B; Racil Z; Schuppert A; Costa I; Koschmieder S; Brümmendorf TH; Gezer D
Ann Hematol; 2021 Dec; 100(12):2943-2956. PubMed ID: 34390367
[TBL] [Abstract][Full Text] [Related]
27. Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage.
Niu LT; Wang YQ; Wong CCL; Gao SX; Mo XD; Huang XJ
Transl Oncol; 2021 Sep; 14(9):101159. PubMed ID: 34252711
[TBL] [Abstract][Full Text] [Related]
28. Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.
Grandits AM; Wieser R
Exp Hematol; 2021 Jul; 99():1-11. PubMed ID: 34029637
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness.
Grandits AM; Nguyen CH; Schlerka A; Hackl H; Sill H; Etzler J; Heyes E; Stoiber D; Grebien F; Heller G; Wieser R
Leukemia; 2021 Oct; 35(10):2827-2839. PubMed ID: 33782537
[TBL] [Abstract][Full Text] [Related]
30. Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches.
Krenn PW; Koschmieder S; Fässler R
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24326-24335. PubMed ID: 32929022
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia.
Parting O; Langer S; Kuepper MK; Wessling C; Li S; Braunschweig T; Chatain N; Maié T; Costa IG; Crysandt M; Huber M; Brümmendorf TH; Koschmieder S; Schemionek M
Leukemia; 2020 Oct; 34(10):2635-2647. PubMed ID: 32684632
[TBL] [Abstract][Full Text] [Related]
32. Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia.
Herrmann O; Kuepper MK; Bütow M; Costa IG; Appelmann I; Beier F; Luedde T; Braunschweig T; Koschmieder S; Brümmendorf TH; Schemionek M
BMC Cancer; 2019 Jul; 19(1):658. PubMed ID: 31272418
[TBL] [Abstract][Full Text] [Related]
33. Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma.
Nadeem Abbas M; Kausar S; Wang F; Zhao Y; Cui H
Cells; 2019 Apr; 8(4):. PubMed ID: 31013819
[TBL] [Abstract][Full Text] [Related]
34. Computational analysis of the evolutionarily conserved Missing In Metastasis/Metastasis Suppressor 1 gene predicts novel interactions, regulatory regions and transcriptional control.
Petrov P; Sarapulov AV; Eöry L; Scielzo C; Scarfò L; Smith J; Burt DW; Mattila PK
Sci Rep; 2019 Mar; 9(1):4155. PubMed ID: 30858428
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-324-5p suppresses the migration and invasion of MM cells by inhibiting the SCF
Zhang L; Liu D; Tang B; Xu A; Huang H; Su Y; Xu J; Deng J; Tang L; Sun C; Hu Y
Oncol Lett; 2018 Oct; 16(4):5331-5338. PubMed ID: 30250603
[TBL] [Abstract][Full Text] [Related]
36. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer.
Vadakekolathu J; Al-Juboori SIK; Johnson C; Schneider A; Buczek ME; Di Biase A; Pockley AG; Ball GR; Powe DG; Regad T
Cell Death Dis; 2018 Mar; 9(3):344. PubMed ID: 29497041
[TBL] [Abstract][Full Text] [Related]
37. Missing-in-metastasis protein downregulates CXCR4 by promoting ubiquitylation and interaction with small Rab GTPases.
Li L; Baxter SS; Gu N; Ji M; Zhan X
J Cell Sci; 2017 Apr; 130(8):1475-1485. PubMed ID: 28264927
[TBL] [Abstract][Full Text] [Related]
38. Mtss1
Fahrenkamp D; Herrmann O; Koschmieder S; Brümmendorf TH; Schemionek M
Leukemia; 2017 Apr; 31(4):1017-1019. PubMed ID: 28167834
[No Abstract] [Full Text] [Related]
39. Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis.
Agarwal E; Robb CM; Smith LM; Brattain MG; Wang J; Black JD; Chowdhury S
Oncogene; 2017 Jun; 36(22):3104-3118. PubMed ID: 28068324
[TBL] [Abstract][Full Text] [Related]
40. MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motility.
Luxen D; Gielen GH; Waha A; Isselstein L; Müller T; Koch P; Hammes J; Becker A; Simon M; Wurst P; Endl E; Pietsch T; Gessi M; Waha A
Transl Oncol; 2017 Feb; 10(1):70-79. PubMed ID: 27988423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
